SPDR Series Trust - SPDR S&P Pharmaceuticals ETF reported earnings results for the full year ended June 30, 2023. For the full year, the company reported revenue was USD 3.53 million. Net loss was USD 5.01 million.
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF
Equities
XPH
US78464A7220
Investment Trusts
1st Jan change | Capi. | |
---|---|---|
+10.99% | 14.85B | |
+9.15% | 6.57B | |
+17.53% | 4.55B | |
+13.31% | 4.48B | |
-4.95% | 4.14B | |
+2.13% | 3.51B | |
+12.33% | 3.38B | |
+11.86% | 3.16B | |
+12.89% | 2.87B |